Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 22, Number 3—March 2016
Synopsis

Avian Influenza A(H5N1) Virus in Egypt

Ghazi KayaliComments to Author , Ahmed Kandeil, Rabeh El-Shesheny, Ahmed S. Kayed, Asmaa M. Maatouq, Zhipeng Cai, Pamela McKenzie, Richard Webby, Samir El Refaey, Amr Kandeel, and Mohamed A. Ali
Author affiliations: St. Jude Children’s Research Hospital, Memphis, Tennessee, USA (G. Kayali, P.P. McKenzie, R.J. Webby); National Research Centre, Giza, Egypt (A. Kandeil, R. El-Shesheny, A.S. Kayed, A.M. Maatouq, M.A. Ali); Georgia State University, Atlanta, Georgia, USA (Z. Cai); Ministry of Health and Population, Cairo, Egypt (S. El Refaey, A. Kandeel)

Main Article

Table 2

H5 commercial inactivated oil-emulsion vaccines used for immunization of poultry against avian influenza A(H5N1) virus, Egypt, 2006

Vaccine trade name
Virus used
Lineage
Sequence similarity, %
Manufacturer, city, country
AI-VAC H5 A/chicken/Italy/22A/1998(H5N9) Classical 90.7 FATRO, Ozzano dell'Emilia, Italy
CEVAC FLUKEM A/chicken/Mexico/232/1994(H5N2) Classical 84 Ceva, Mexico City, Mexico
VOLVAC IV KV A/chicken/Mexico/232/1994(H5N2) Classical 84 Boehringer Ingelheim, Ingelheim am Rhein, Germany
AIV Vaccine A/turkey/Engl and /N28/1973(H5N2) Classical 91.4 Yebio, Qingdao, China
AIV Vaccine A/turkey/Minnesota/3689–1551/1981(H5N2) Classical 89.8 Lohmann, Waterville, Maine, United States
Nobilis Influenza H5N2 A/duck/Potsdam/1402/1986(H5N2) Classical 91.6 Merck, Kenilworth, New Jersey, United States
Optimune AIV A/turkey/Wisconsin/1968(H5N9) Classical 88.3 Ceva Biomune, Mexico City, Mexico
Avian Influenza H5 A/chicken/Mexico/232/1994(H5N2) Classical 84 Avimex Animal Health Mexico City, Mexico
VOLVAC IV +ND KV A/chicken/Mexico/232/94(H5N2) and Lasot and V Classical 84 Boehringer Ingelheim, Ingelheim am Rhein, Germany
CEVAC NEW FLU-KEM A/chicken/Mexico/232/94(H5N2) and Lasot and V Classical 84 Ceva, Mexico City, Mexico
ITA FLU A/chicken/Mexico/232/1994(H5N2) Classical 84 Laprovet, Notre-Dame-d’Oé, France
Reassortant AIV (subtype H5N1) Vaccine (strain Re-1) RGA/goose/Guangdong/1996(H5N1)(Re-1) Clade 0 93.8 Zhaoqing DaHuaNong Biology Medicine, Sihui, China
Reassortant AIV (Subtype H5N1) Vaccine (srain Re-1) RGA/goose/Guangdong/1996(H5N1)(Re-1) Clade 0 93.8 Yebio, Qingdao, China
PoulvacFluFend H5N3 RG RGA/chicken/VN/C58/2004(H5N3) Clade 1 95.1 Fort Dodge Animal Health, Fort Dodge, Iowa, USA
MEFLUVAC RGA/chicken/Egypt/Q1995D/2010(H5N1) and RGA/chicken/Egypt/M2583D/2010(H5N1) Clade 2.2 93.8 and 99.6 ME-VAC, Cairo, Egypt
SER-VACC FLU RGA/chicken/Egypt/M2583D/2010(H5N1) Clade 2.2 99.6 Veterinary Serum and Vaccine Institute, Cairo, Egypt
ME FLUVAC H5+H9 RGA/chicken/Egypt/Q1995D/2010(H5N1)
and A/chicken/Egypt/114940v/NLQP/2011(H9N2) Clade 2.2 93.8 ME-VAC, Cairo, Egypt
ME FLUVAC One RGA/duck/Egypt/M2583D/2010(H5N1) Clade 2.2 99.6 ME-VAC, Cairo, Egypt
ME FLUVACH5+ ND RGA/chicken/Egypt/Q1995D/2010(H5N1) and NDV/chicken/Egypt/11478AF/2011(ND) Clade 2.2 93.8 ME-VAC, Cairo, Egypt
ME FLUVAC Super H5 +H9+ ND RGA/chicken/Egypt/Q1995D/2010(H5N1), RGA/duck/Egypt/M2583D/2010(H5N1), A/chicken/Egypt/114940v/NLQP/2011(H9N2), and NDV/chicken/Egypt/11478AF/2011(ND) Clade 2.2 93.8 and 99.6 ME-VAC, Cairo, Egypt
Egy FLU RGA/chicken/Egypt/18-H/2009(H5N1) Clade 2.2 94.9 Harbin Veterinary Research Institute, Harbin, China
Inactivated Reassortant Avian Influenza Virus Vaccine (H5N1 Subtype, Re-6 Strain) RGA/duck/Guangdong/S1322/2006(H5N1)(Re-6) Clade 2.3.2 Not performed Yebio, Qingdao, China
Reassortant AIV (Subtype H5N1) Vaccine (Strain Re-5) RGA/duck/Anhui/1/2006(H5N1)(Re-5) Clade 2.3.4 94.9 Merial, Duluth, Georgia, United States
Reassortant AIV (Subtype H5N1) Vaccine (Strain Re-5) RGA/duck/Anhui/1/2006(H5N1)(Re-5) Clade 2.3.4 94.9 QYH, Beijing, China

Main Article

Page created: February 16, 2016
Page updated: February 16, 2016
Page reviewed: February 16, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external